Prostate News and Research

RSS

Risks of cancer and mortality found to be lowest in light drinkers

The risk of mortality, and of developing a number of cancers, is lowest in light drinkers consuming an average of less than one drink per day across their lifetime, and the risk of some cancers increases with each additional drink per week, according to a new study, published this week in PLOS Medicine by Andrew Kunzmann of Queen’s University Belfast, and colleagues.

20 Jun 2018

Monash study reveals why older people have reduced immune responses to cancer therapy

It's called the Silver Tsunami - the increased incidence of cancer with aging, combined with the rapidly aging population means that the Australian health system needs to prepare for an onslaught of cancer diagnoses.

20 Jun 2018

Lifestyle intervention could normalize unhealthy behaviors that lead to cancer, chronic disease

Does this sound like someone you know? He or she spends too much time in front of screens, gets little exercise and eats a diet high in fat and low in fruits and vegetables.

19 Jun 2018

Study finds combined risk of death and developing cancer to be lowest in light drinkers

A new study, led by Dr Andrew Kunzmann, researcher from the School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast, has found the combined risk of death and developing a number of cancers is lowest in light drinkers, consuming less than one drink per day, and increases with each additional drink per week.

19 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

Scientists develop novel computational framework to support personalized cancer treatment

Researchers at Columbia University Irving Medical Center have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them.

19 Jun 2018

Diabetes diagnosis may come with increased risk of pancreatic cancer for African-Americans, Latinos

Each year, more than one million Americans are diagnosed with adult-onset diabetes mellitus, also known as type 2 diabetes. The new diagnosis comes with a long list of potential complications: high blood pressure, nerve damage, kidney disease, stroke, glaucoma and more.

18 Jun 2018

Recent-onset type 2 diabetes may be early expression of pancreatic cancer

A new study in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that recent-onset type 2 diabetes may be early expression of pancreatic cancer.

18 Jun 2018

Scientists identify new subtype of prostate cancer

Researchers led by the University of Michigan Rogel Cancer Center have identified a new subtype of prostate cancer that occurs in about 7 percent of patients with advanced disease.

14 Jun 2018

Genetic testing of prostate tumors could identify likely responders to immunotherapy

Scientists have identified a pattern of genetic changes that could pick out men with advanced prostate cancer who are likely to benefit from immunotherapy.

14 Jun 2018

Patients may want cancer screenings even if potential harms outweigh benefits, finds study

A large proportion of the American public opts to receive cancer screenings with the hope that testing will reduce their chance of cancer death.

14 Jun 2018

Physicians test technique to preserve potency in men undergoing prostate cancer therapy

"Will treatment make me impotent?" It's a question on the minds of many men as they are making decisions about prostate cancer treatment.

13 Jun 2018

OGT increases NGS cancer panel content to provide more flexibility for customization

Oxford Gene Technology, The Molecular Genetics Company, has expanded its SureSeq myPanel™ NGS Custom Cancer Panel content - now covering 120 fully optimized cancer related genes.

From Oxford Gene Technology 13 Jun 2018

Studies show link between innovation and reduced surgery complications

Exciting data from the 26th European Society of Thoracic Surgeons meeting shows an association between innovation, and improved patient outcomes and lowered hospital costs

13 Jun 2018

Research identifies new genetic variations that could indicate higher prostate cancer risk

As the result of a six-year long research process, Fredrick R. Schumacher, PhD, a cancer epidemiology researcher at Case Western Reserve University School of Medicine, and an international team of more than 100 colleagues have identified 63 new genetic variations that could indicate higher risk of prostate cancer in men of European descent.

12 Jun 2018

New DNA test identifies men at highest risk of prostate cancer

A major new study of more than 140,000 men has identified 63 new genetic variations in the DNA code that increase the risk of prostate cancer.

11 Jun 2018

Men's Health Week

A series of articles for Men's Health Week 2018.

11 Jun 2018

Improving the quality of American's diet could reduce health-related costs, suggests study

What we eat has important implications for our health - and for what we spend on healthcare. New research suggests improving the quality of the average American's diet could substantially reduce costs associated with heart disease, diabetes, cancer and other major health problems.

11 Jun 2018

NeoTract announces results of study measuring costs and patient outcomes of UroLift System

NeoTract, a wholly owned subsidiary of Teleflex Incorporated focused on addressing unmet needs in the field of urology, today announced the results of an independent analysis measuring costs and patient outcomes of the UroLift System compared to transurethral resection of the prostate.

8 Jun 2018

New type of sensor acts like Velcro for prostate cancer cells

Researchers have developed a new type of sensor that acts like Velcro for prostate cancer cells, sticking them to a modified frosted glass slide, like those used in science classes, so that they can be identified from blood samples.

7 Jun 2018

Prostate News and Research

Risks of cancer and mortality found to be lowest in light drinkers

Monash study reveals why older people have reduced immune responses to cancer therapy

Lifestyle intervention could normalize unhealthy behaviors that lead to cancer, chronic disease

Study finds combined risk of death and developing cancer to be lowest in light drinkers

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Scientists develop novel computational framework to support personalized cancer treatment

Diabetes diagnosis may come with increased risk of pancreatic cancer for African-Americans, Latinos

Recent-onset type 2 diabetes may be early expression of pancreatic cancer

Scientists identify new subtype of prostate cancer

Genetic testing of prostate tumors could identify likely responders to immunotherapy

Patients may want cancer screenings even if potential harms outweigh benefits, finds study

Physicians test technique to preserve potency in men undergoing prostate cancer therapy

OGT increases NGS cancer panel content to provide more flexibility for customization

Studies show link between innovation and reduced surgery complications

Research identifies new genetic variations that could indicate higher prostate cancer risk

New DNA test identifies men at highest risk of prostate cancer

Men's Health Week

Improving the quality of American's diet could reduce health-related costs, suggests study

NeoTract announces results of study measuring costs and patient outcomes of UroLift System

New type of sensor acts like Velcro for prostate cancer cells

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News